The Takeda Pharmaceutical Co. and Frazier Healthcare Partners recently launched Outpost Medicine, a new company in the biopharmaceutical field that will focus on developing new treatment options for urologic and gynecologic diseases and disorders. Read More »
Pfizer has announced that it will be presenting new data based on the research of tofacitinib in ulcerative colitis (UC) and Crohn’s disease at the 11th Congress of ECCO, which is scheduled for March 16-19 in Amsterdam. Read More »
The CVS Health Foundation has announced a second round of grants in collaboration with the Campaign for Tobacco-Free Kids that will be awarded through the grant program known as “Making the Next Generation Tobacco-Free.” Read More »
The Center for Disease Control (CDC) has released new guidelines that provide recommendations that will enhance the care and safety of patients that have been prescribed opioids for chronic pain. Read More »
Aetna made an announcement last week naming New Century Health (NCH) a preferred national solution partner for oncology. Read More »
Sanofi and Regeneron Pharmaceuticals announced that the Phase 3 study of monotherapies set to demonstrate the superiority of sarilumab to adalimumab when treating active rheumatoid arthritis (RA) has met its primary goal. Read More »
Pfizer today released its 2015 integrated annual review, which is an in-depth look at the company’s financial, social and environmental performance. Read More »
Amgen has announced that its supplemental Biologics License Application (sBLA) for the extended use of Enbrel (etanercept) in the treatment of chronic severe plaque psoriasis in pediatric patients has been accepted for review by the U.S. Food and Drug Administration (FDA). Read More »
Pharmacyclics LLC, an AbbVie company, and Janssen Biotech Inc., developers of the award-winning drug Imbruvica (ibrutinib) aim to continue enhancing the cancer-fighting drug’s clinical meaningfulness. Read More »
AstraZeneca and MedImmune have announced that the U.S. Food and Drug Administration (FDA) has granted MEDI-551, an anti-CD19 monoclonal antibody, Orphan Drug Designation. Read More »
Pfizer recently published the results to its Phase 3 study of BeneFIX Coagulation Factor IX (recombinant) 100 IU/kg prophylaxis compared to on-demand treatment for patients with moderately severe or severe hemophilia B. Read More »
Prime Therapeutics announced last week that it will start the management of pharmacy benefits for Blue Cross & Blue Shield of Rhode Island (BCBSRI) beginning on Jan 1, 2017. Read More »
Veloxis Pharmaceuticals has announced the closing of its Horsholm, Denmark office and that it will be relocating to the United States. Read More »
McKesson has announced the release of Conserus Imaging Fellow. Read More »
Governors and physicians have come together to call for a resolution to the United States’s opioid epidemic. Read More »
The American Society of Health-System Pharmacists (ASHP) has announced its 2016 Board of Directors’ Awards recipients. Read More »
Walgreens has announced, in accordance with its goal to combat drug abuse in the United States, that it has made naloxone available in its Ohio pharmacies without a prescription. Read More »
XYMOGEN announced that it has been awarded a prestigious certification from Australia's Therapeutic Goods Administration (TGA). Read More »
Robert M. Califf, M.D., will be appointed the new commissioner of the U.S. Food and Drug Administration (FDA) after the Senate recently voted in favor of his appointment, 89-4. Read More »
The US Oncology Network has announced the launch of a new groundbreaking program that was developed to aid oncologists from around the country prepare for the execution of the new Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) and other alternate payment models. Read More »
Alerts Sign-up
